Rivals to XBI and PBE, including the iShares Nasdaq Biotechnology ETF (NasdaqGM: IBB) and the First Trust NYSE Arca Biotechnology Index Fund (NYSEArca: FBT), feature little to no exposure to Idenix. IBB, the largest biotech ETF, allocates 0.24% to Idenix while the stock is not a member of FBT’s portfolio.

The $499.9 million Market Vectors Biotech ETF (NYSEArca: BBH) also does not feature Idenix among its holdings.

SPDR S&P Biotech ETF

 

ETF Trends editorial team contributed to this post

Subscribe to our free daily newsletters!
Please enter your email address to subscribe to ETF Trends' newsletters featuring latest news and educational events.